Solomon Islands vs Togo: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Solomon Islands
1.4%
in 2024
Togo
1.4%
in 2024
Solomon Islands rank
22nd
Togo rank
22nd
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Solomon Islands
- Togo
How they compare
Solomon Islands currently reports 1.4% against 1.4% in Togo, a difference of 0.0%.
The two have swapped places 3 times across 10 shared years of data; in 2015 it was Solomon Islands ahead.
Solomon Islands ranks 22nd and Togo ranks 22nd of 246 countries.
Solomon Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Solomon Islands | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.1% | 1.9% | 0.1% | Solomon Islands |
| 2020s | 1.6% | 1.5% | 0.1% | Solomon Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Solomon Islands or Togo?
- Solomon Islands, at 1.4% against 1.4% in Togo as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Solomon Islands and Togo?
- 0.0%, with Solomon Islands ahead.
- How many years of comparable data are there for Solomon Islands and Togo?
- 10 years are reported by both, from 2015 to 2024.
- How do Solomon Islands and Togo rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Solomon Islands ranks 22nd and Togo ranks 22nd of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.